Seres Therapeutics
MCRB
MCRB
89 hedge funds and large institutions have $308M invested in Seres Therapeutics in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 37 increasing their positions, 18 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $382M → $308M (-$74.2M)
28% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 18
46% less call options, than puts
Call options by funds: $292K | Put options by funds: $544K
Holders
89
Holding in Top 10
1
Calls
$292K
Puts
$544K
Top Buyers
| 1 | +$2.23M | |
| 2 | +$2.22M | |
| 3 | +$1.98M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.14M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.08M |
Top Sellers
| 1 | -$9.22M | |
| 2 | -$4.35M | |
| 3 | -$2.19M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$1.74M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$1.64M |